Otsuka Holdings
4578.T
#699
Rank
โ‚น3.454 T
Marketcap
โ‚น6,574
Share price
2.20%
Change (1 day)
62.60%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น340.12. In 2025 the company made an earnings per share (EPS) of โ‚น422.88 an increase over its 2024 EPS that were of โ‚น389.76.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-27.22%
2025โ‚น422.888.5%
2024โ‚น389.76153.9%
2023โ‚น153.51-15.71%
2022โ‚น182.12-6.18%
2021โ‚น194.11-24.1%
2020โ‚น255.7522.95%
2019โ‚น208.0156.13%
2018โ‚น133.23-25.11%
2017โ‚น177.9125.99%
2016โ‚น141.21-6.37%
2015โ‚น150.83
2014N/A-100%
2013โ‚น227.2418.06%
2012โ‚น192.471.01%
2011โ‚น190.5429.07%
2010โ‚น147.63-94.47%
2009โ‚น2,669